Director of Quantum-Si Sells Shares Worth Over $11 Million

On December 27th, Jonathan M. Rothberg, a director at Quantum-Si incorporated (NASDAQ:QSI), sold a significant portion of his shares in the company. A total of 3,506,267 shares were sold at an average price of $3.34, culminating in a total value of approximately $11,710,931.78. After this transaction, Rothberg retains ownership of 1,250,000 shares, which are currently valued at around $4,175,000. This sale reflects a notable reduction in his holdings, representing a 73.72% decrease.

Market Performance of Quantum-Si

On a recent trading day, Quantum-Si's shares dipped by $0.63, settling at $2.70. During this trading session, a total of 43,231,980 shares changed hands, a significant increase from the average trading volume of 5,195,960. Over the past year, the stock has experienced a low of $0.61 and a high of $4.14. The company's market capitalization stands at approximately $385.33 million, with a P/E ratio of -4.22 and a beta of 3.20. The fifty-day moving average is $1.25, while the 200-day moving average is $1.07.

Institutional Investor Activity

Recent activity from institutional investors highlights shifts in holdings at Quantum-Si. Geode Capital Management LLC has increased its holdings by 6.7% during the third quarter, now owning 2,316,921 shares valued at $2,044,000 after acquiring an additional 145,091 shares. Barclays PLC has significantly boosted its position by 210.5%, currently holding 196,826 shares valued at $173,000 after purchasing 133,438 shares. Other firms such as SG Americas Securities LLC and Green Alpha Advisors LLC have also adjusted their stakes in the company. Notably, 39.90% of Quantum-Si's stock is owned by institutional investors.

Analyst Commentary

In the realm of analyst ratings, Quantum-Si has recently received mixed evaluations. HC Wainwright raised its price target from $4.00 to $5.50, designating the stock with a "buy" rating. Conversely, Canaccord Genuity Group lowered its price target from $1.50 to $1.00, advising a "hold" on the stock.

About the Company

Quantum-Si incorporated is a life sciences firm focused on the development of a single-molecule detection platform to facilitate Next Generation Protein Sequencing (NGPS). The platform is built around the Platinum NGPS instrument along with supporting software, reagent kits, and semiconductor chips essential for its operations.

Investment Considerations

Investors should remain informed about the performance of Quantum-Si stock, especially given its current moderate buy rating among analysts. Potential investors need to weigh their options with other recommended stocks before making any decisions.

Quantum-Si, Stock, Sale